Clinical Trials Directory

Trials / Completed

CompletedNCT05681234

Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Affiliated Hospital of Jiangnan University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a single arm study to evaluate the safety and biodistribution of 18F-labeled RD2 PET/CT Imaging in patients with small liver carcinoma.

Conditions

Interventions

TypeNameDescription
RADIATION18F-RD2Patients will receive 5-10 mCi 18F-RD2

Timeline

Start date
2022-08-24
Primary completion
2022-11-02
Completion
2022-12-20
First posted
2023-01-12
Last updated
2023-01-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05681234. Inclusion in this directory is not an endorsement.

Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma (NCT05681234) · Clinical Trials Directory